Skip to main content
SpringerLink
Log in

Is Indeterminate Colitis Determinable?

  • Inflammatory Bowel Disease (SB Hanauer, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

About 10% of patients with colitis due to inflammatory bowel disease have indeterminate colitis. Despite newer diagnostic tools, the frequency has not diminished over the past 33 years. The current preferred term among academicians is colonic inflammatory bowel disease unclassified (IBDU), although indeterminate colitis is the term endorsed for inclusion in the ICD-10 coding system. Indeterminate colitis is more frequent among children. The anti-Saccharomyces cerevisiae (ASCA) and perinuclear anti-cytoplasmic antibody (pANCA) are useful in distinguishing IBDU from ulcerative colitis and Crohn’s disease. However, current serologic and genetic studies, as well as endoscopic and imaging studies lack sufficient positive predictive values to make a definite diagnosis of Crohn’s colitis or ulcerative colitis. Patients with IBDU who undergo proctocolectomy with ileal pouch-anal anastomosis have more complications than patients with ulcerative colitis. Although some patients with indeterminate colitis eventually develop characteristic ulcerative colitis or Crohn’s disease, a subgroup are durably indeterminate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease–‘colitis indeterminate’. J Clin Pathol. 1978;31:567–77.

    Article  PubMed  CAS  Google Scholar 

  2. Tremaine WJ. Review article: Indeterminate colitis–definition, diagnosis and management. Aliment Pharmacol Ther. 2007;25:13–7.

    Article  PubMed  CAS  Google Scholar 

  3. Pera A, Bellando P, Caldera D, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology. 1987;92:181–5.

    PubMed  CAS  Google Scholar 

  4. Jarry M, Soussan EB, Boureille A, et al. The value of wireless capsule enteroscopy (wce) in indeterminate colitis. Gastroenterology. 2005;128:A-306.

    Google Scholar 

  5. • Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5–36. This report has an excellent summary of data referable to indeterminate colitis and introduced the term IBDU with an explanation of why yet another term is needed.

    PubMed  Google Scholar 

  6. Meucci G. What is the incidence, prevalence, and natural history of indeterminate colitis? Inflamm Bowel Dis. 2008;14 Suppl 2:S159–60.

    Article  PubMed  Google Scholar 

  7. Lindberg E, Lindquist B, Holmquist L, Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984–1995. J Pediatr Gastroenterol Nutr. 2000;30:259–64.

    Article  PubMed  CAS  Google Scholar 

  8. Prenzel F, Uhlig HH. Frequency of indeterminate colitis in children and adults with IBD—a metaanalysis. J Crohns Colitis. 2009;3:277–81.

    Article  PubMed  Google Scholar 

  9. Geboes K, Colombel JF, Greenstein A, et al. Indeterminate colitis: a review of the concept–what’s in a name? Inflamm Bowel Dis. 2008;14:850–7.

    Article  PubMed  Google Scholar 

  10. Antonioli DA. Pediatric inflammatory bowel disease. Pediatr Dev Pathol. 2005;8:2–19.

    Article  PubMed  Google Scholar 

  11. Wells AD, McMillan I, Price AB, et al. Natural history of indeterminate colitis. Br J Surg. 1991;78:179–81.

    Article  PubMed  CAS  Google Scholar 

  12. Stordal K, Jahnsen J, Bentsen BS, Moum B. Pediatric inflammatory bowel disease in southeastern Norway: a five-year follow-up study. Digestion. 2004;70:226–30.

    Article  PubMed  Google Scholar 

  13. Yu CS, Pemberton JH, Larson D. Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Dis Colon Rectum. 2000;43:1487–96.

    Article  PubMed  CAS  Google Scholar 

  14. Farmer M, Petras RE, Hunt LE, et al. The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am J Gastroenterol. 2000;95:3184–8.

    Article  PubMed  CAS  Google Scholar 

  15. • Bourreille A, Ignjatovic A, Aabakken L, et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy. 2009;41:618–37. This is a comprehensive review of the data on capsule endoscopy in IBD with sound recommendations.

    Article  PubMed  CAS  Google Scholar 

  16. Mow WS, Lo SK, Targan SR, et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2:31–40.

    Article  PubMed  Google Scholar 

  17. Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133–41.

    Article  PubMed  Google Scholar 

  18. •• Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122:1242–7. This is the only prospective study on Indeterminate Colitis. It is basis for the follow-up report, reference 19.

    Article  PubMed  Google Scholar 

  19. •• Joossens S, Colombel JF, Landers C, et al. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut. 2006;55:1667–9. This study clearly demonstrates that there is no added value at present to testing for additional serologies beyond pANCA and ASCA to categorize the type of IBD.

    Article  PubMed  CAS  Google Scholar 

  20. Hui T, Landers C, Vasiliauskas E, et al. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation. Dis Colon Rectum. 2005;48:1254–62.

    Article  PubMed  Google Scholar 

  21. Vermeire S. NOD2/CARD15: relevance in clinical practice. Best Pract Res Clin Gastroenterol. 2004;18:569–75.

    Article  PubMed  CAS  Google Scholar 

  22. Weersma RK, Stokkers PC, Cleynen I, et al. Confirmation of multiple Crohn’s disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol. 2009;104:630–8.

    Article  PubMed  CAS  Google Scholar 

  23. Vermeire S. To what extent are genetics clinically useful? Best Pract Res Clin Gastroenterol. 2011;25:S8–S14.

    Article  PubMed  Google Scholar 

  24. Papadakis KA, Treyzon L, Abreu MT, et al. Infliximab in the treatment of medically refractory indeterminate colitis. Aliment Pharmacol Ther. 2003;18:741–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street, SW, Rochester, MN, 55905, USA

    William J. Tremaine

Authors
  1. William J. Tremaine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William J. Tremaine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tremaine, W.J. Is Indeterminate Colitis Determinable?. Curr Gastroenterol Rep 14, 162–165 (2012). https://doi.org/10.1007/s11894-012-0244-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-012-0244-x

Keywords

Search

Navigation